Genomic Valley Biotech Limited (GVBL) Share Price

BSE · Healthcare · Biotechnology · ISIN INE574D01010

₹29.88+0.00 (+0.00%)

Key metrics

Market Cap
₹9 Cr
P/E Ratio
426.86
EPS
0.07
Book Value
12.86
P/B Ratio
2.32
ROE
0.77%
ROCE
1.02%
Debt / Equity
Net Margin
11.33%
Revenue Growth
-68.3%
Profit Growth
-91.49%
Dividend Yield
52W High
₹41.95
52W Low
₹20.10
Market Cap Band
micro cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Genomic Valley Biotech Limited

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It also undertakes contracts for its clients for erecting greenhouses; and provides turnkey consultancy services. In addition, the company manufactures and markets bio-fertilizers; and offers farmer support apps. Further, it is involved in the operation of plant tissue culture process laboratory to produce tissue cultured plantlets. The company was incorporated in 1994 and is based in Delhi, India.

Headquarters
Delhi, India
Promoter Holding
74.84%

The full Genomic Valley Biotech Limited analysis

Create a free account to open the complete GVBL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.